Vaccine composition
US9498527B2 · kind B2 · utility
5Cited by
0References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 3, 2013 |
| Grant date | Nov 22, 2016 |
| Priority date | — |
| Expiry date | Apr 3, 2033 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
An intraorally administrable vaccine composition useful to be a preventive or therapeutic agent for infectious diseases, and effectively induces a systemic immune response or a mucosal immune response is provided. A vaccine composition for administration to the oral cavity of a human or an animal, the vaccine composition containing at least one antigen derived from an infectious disease, and at least one selected from the group consisting of a toll-like receptor 4 (TLR4) agonist, a toll-like receptor 2/6 (TLR2/6) agonist, and cyclic dinucleotide, or a derivative or salt thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.